Advances in Interventional Cardiology (Aug 2022)

Effectiveness and safety of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with familial hypercholesterolemia. Our experience in implementing the drug program of the Polish National Health Fund

  • Beata Bobrowska,
  • Agata Krawczyk-Ożóg,
  • Stanisław Bartuś,
  • Renata Rajtar-Salwa

DOI
https://doi.org/10.5114/aic.2022.118533
Journal volume & issue
Vol. 18, no. 2
pp. 162 – 166

Abstract

Read online

No abstracts available.

Keywords